SCHEMBL7255249

SCHEMBL7255249

CC1(C)Cc2cc(CC(C)(N)C(=O)O)ccc2O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.51
▸ BLM P54132 2/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ USP2 O75604 1/20 0.51
▸ EGFR P00533 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ FYN P06241 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ APEX1 P27695 1/20 0.51
▸ ADRA1A P35348 1/20 0.51
▸ PTGS2 P35354 1/20 0.51
▸ MTOR P42345 1/20 0.51
▸ RECQL P46063 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255253 1.00 GAA (0.51) GAABLMKDM4EALDH1A1HPGD
SCHEMBL13547930 0.81 HIF1A (0.42) MAPTMEN1KMT2ASSTR5HIF1A
SCHEMBL17316361 0.78 SSTR5 (0.46) GAABLMKDM4EALDH1A1HPGD
SCHEMBL17316417 0.74 HIF1A (0.41) GAAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL13156334 0.74 HIF1A (0.44) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL6718864 0.74 CYP3A4 (0.57) GAABLMKDM4EALDH1A1HPGD
SCHEMBL13957646 0.74 CYP3A4 (0.57) GAABLMKDM4EALDH1A1HPGD
SCHEMBL8188120 0.73 HIF1A (0.45) MAPTMEN1KMT2ASSTR5HIF1A
SCHEMBL8225530 0.73 HIF1A (0.44) MAPTMEN1KMT2ASSTR5HIF1A
SCHEMBL20766930 0.72 HIF1A (0.46) GAAALDH1A1MAPTSSTR5HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555663-B1 Pharmaceuticals which are activated intracellularly by reaction with cellular electron carriers or free radicals to cause release of a free and active drug molecule MILLS RANDELL LEE (US) 2003-04-29 — — US disclosed
US-5428163-A Luminides; chemiluminescence; redox system, releasing free drug MILLS RANDELL L (US) 1995-06-27 — — US disclosed
EP-0414730-A4 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS — 1993-06-16 — — EP disclosed
EP-0414730-A1 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS Mills, Randell L. (US) 1991-03-06 — — EP disclosed
WO-1989009833-A1 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS MILLS RANDELL L (US) 1989-10-19 — — WO disclosed
Send feedback